AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33269395 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine plus celecoxib
Number of subjects: 122
Study 33269395 — intervention group
Group type: COMPARATOR
Intervention: Vortioxetine plus placebo
Number of subjects: 122
Study 32623288 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab-based treatment (induction with panitumumab-FOLFOX followed by maintenance with single-agent panitumumab)
Number of subjects: 0
Study 32623288 — intervention group
Group type: COMPARATOR
Intervention: Single-agent panitumumab (after 4-month induction with panitumumab-FOLFOX)
Number of subjects: 0
Study 32326749 — intervention group
Group type: EXPERIMENTAL
Intervention: START program
Number of subjects: 8
Study 32016367 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational data
Number of subjects: 0
Study 32016367 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0
Study 32016367 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic RCTs
Number of subjects: 0
Study 32016367 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of electronic health records (EHRs) for patient recruitment and follow-up
Number of subjects: 0
Study 34927539 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopy
Number of subjects: 46
Study 34927539 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopy
Number of subjects: 46
Study 32057631 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 47
Study 32057631 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 47
Study 33463020 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based exercise training (IBET)
Number of subjects: 350
Study 33463020 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard physical therapy (PT)
Number of subjects: 350
Study 33463020 — intervention group
Group type: COMPARATOR
Intervention: Standard physical therapy (PT) or internet-based exercise training (IBET)
Number of subjects: 350
Study 34131186 — intervention group
Group type: EXPERIMENTAL
Intervention: FSMS-RUTF
Number of subjects: 0
Study 34131186 — intervention group
Group type: EXPERIMENTAL
Intervention: MSMS-RUTF
Number of subjects: 0
Study 34131186 — intervention group
Group type: COMPARATOR
Intervention: PM-RUTF
Number of subjects: 0
Study 32382926 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium oxalate (Oxa‐Gel BF)
Number of subjects: 74
Study 32382926 — intervention group
Group type: COMPARATOR
Intervention: GaAlAs low‐power laser (100 mW, 808nm, 60 J/cm2)
Number of subjects: 74
Study 32382926 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium oxalate (Oxa‐Gel BF) associated with GaAlAs low‐power laser
Number of subjects: 74
Study 32382926 — intervention group
Group type: COMPARATOR
Intervention: All groups (G1, G2, G3)
Number of subjects: 74
Study 35672866 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fish oil (6.2 g daily)
Number of subjects: 40
Study 35672866 — intervention group
Group type: COMPARATOR
Intervention: Control (no fish oil)
Number of subjects: 40
Study 32464903 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron isomaltoside, 20 mg/kg
Number of subjects: 102
Study 32464903 — intervention group
Group type: COMPARATOR
Intervention: NaCl (control)
Number of subjects: 102
Study 34148021 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive medication adherence
Number of subjects: 1479
Study 34148021 — intervention group
Group type: EXPERIMENTAL
Intervention: Single antihypertensive medication
Number of subjects: 1479
Study 34148021 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple antihypertensive medications
Number of subjects: 1479
Study 34148021 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred classes of antihypertensive drugs
Number of subjects: 1479
Study 32371681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyper-selective posterior fusion (UIV = UEV, LIV = LEV)
Number of subjects: 80
Study 32371681 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyper-selective posterior fusion (UIV = UEV-1)
Number of subjects: 80
Study 32371681 — intervention group
Group type: COMPARATOR
Intervention: Hyper-selective posterior fusion (UIV = UEV)
Number of subjects: 80
Study 34665853 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Cognitive‐Behavioral Social Skills Training and Compensatory Cognitive Training (CBSST‐CCT)
Number of subjects: 55
Study 34665853 — intervention group
Group type: COMPARATOR
Intervention: Goal‐focused Supportive Contact (SC)
Number of subjects: 55
Study 34713983 — intervention group
Group type: EXPERIMENTAL
Intervention: TT+RT (testosterone treatment + resistance training)
Number of subjects: 13
Study 34713983 — intervention group
Group type: COMPARATOR
Intervention: no-TT (testosterone treatment only)
Number of subjects: 13
Study 34713983 — intervention group
Group type: EXPERIMENTAL
Intervention: TT+RT
Number of subjects: 13
Study 34713983 — intervention group
Group type: COMPARATOR
Intervention: no-TT
Number of subjects: 13
Study 32112166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine with intravenous analgesia (ITM-IV)
Number of subjects: 36
Study 32112166 — intervention group
Group type: COMPARATOR
Intervention: Intravenous analgesia without intrathecal morphine (IV)
Number of subjects: 36
Study 34210788 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 3
Study 34210788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 36166405 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high dose (10 mg/kg) of liposomal amphotericin B with optimized oral backbone of fluconazole and flucytosine
Number of subjects: 0
Study 36166405 — intervention group
Group type: COMPARATOR
Intervention: WHO-recommended regimen of seven days of amphotericin B deoxycholate plus flucytosine
Number of subjects: 0
Study 36166405 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high dose (10 mg/kg) of liposomal amphotericin B
Number of subjects: 0
Study 33940487 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring group (SMG)
Number of subjects: 34
Study 33940487 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 34
Study 35964042 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Referral Scheme (PARS)
Number of subjects: 567
Study 35964042 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity Advice (PAA)
Number of subjects: 567
Study 35964042 — intervention group
Group type: EXPERIMENTAL
Intervention: PARS
Number of subjects: 567
Study 35964042 — intervention group
Group type: COMPARATOR
Intervention: PAA
Number of subjects: 567
Study 35964042 — intervention group
Group type: EXPERIMENTAL
Intervention: PARS and PAA
Number of subjects: 567
Study 34684496 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed dietary pattern
Number of subjects: 202
Study 34684496 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional, vegetarian-alike dietary pattern
Number of subjects: 202
Study 34684496 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Index
Number of subjects: 202
Study 33284338 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP test-guided (CTG)
Number of subjects: 528
Study 33284338 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured clinical monitoring (SCM)
Number of subjects: 528
Study 33284338 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 528
Study 33284338 — intervention group
Group type: EXPERIMENTAL
Intervention: CTG among extreme metabolizers
Number of subjects: 528
Study 33284338 — intervention group
Group type: EXPERIMENTAL
Intervention: SCM among extreme metabolizers
Number of subjects: 528
Study 35218356 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of measles vaccine (MV2) at 18 months of age
Number of subjects: 3164
Study 35218356 — intervention group
Group type: COMPARATOR
Intervention: No vaccine (control group)
Number of subjects: 3164
Study 35218356 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of measles vaccine (MV2) after OPV campaigns
Number of subjects: 3164
Study 35218356 — intervention group
Group type: EXPERIMENTAL
Intervention: Second dose of measles vaccine (MV2)
Number of subjects: 3164
Study 33138210 — intervention group
Group type: EXPERIMENTAL
Intervention: High personalization (structured video calls with a dietitian using the AES report plus dietary self‐monitoring with text message feedback)
Number of subjects: 50
Study 33138210 — intervention group
Group type: EXPERIMENTAL
Intervention: High personalization
Number of subjects: 50
Study 33138210 — intervention group
Group type: COMPARATOR
Intervention: Low personalization (web‐based personalized nutrition feedback report using AES data)
Number of subjects: 50
Study 36127742 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom assessment application (SAA) usage
Number of subjects: 440
Study 36127742 — intervention group
Group type: COMPARATOR
Intervention: Standard care without using a SAA
Number of subjects: 440
Study 33359350 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 200
Study 33359350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 35388309 — intervention group
Group type: EXPERIMENTAL
Intervention: Date Palm Pollen (DPP) 3 grams twice a day for two months
Number of subjects: 60
Study 35388309 — intervention group
Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 60
Study 34475139 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride
Number of subjects: 460
Study 34475139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 460
Study 32193662 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 20
Study 32193662 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 20
Study 36401339 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF) 240 mg twice daily
Number of subjects: 87
Study 36401339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 33031534 — intervention group
Group type: EXPERIMENTAL
Intervention: Active choice intervention
Number of subjects: 11693
Study 33031534 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive choice intervention
Number of subjects: 11693
Study 33031534 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11693
Study 33184146 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 60,000 IU daily for 7 days
Number of subjects: 40
Study 33184146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33873106 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel loading conditions
Number of subjects: 23
Study 34293634 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based early stimulation program targeting visual and motor functions (ESPVM)
Number of subjects: 30
Study 34293634 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 30
Study 33044283 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation with driving pressure of 20 cm H2O for 2 hours (phase 2)
Number of subjects: 10
Study 33044283 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure for 2 hours (phase 3)
Number of subjects: 10
Study 33044283 — intervention group
Group type: COMPARATOR
Intervention: Pressure-controlled ventilation with driving pressure of 10 cm H2O for 4 hours (phase 4)
Number of subjects: 10
Study 36419197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 103
Study 36419197 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 103
Study 32208487 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 42
Study 32208487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34803148 — intervention group
Group type: COMPARATOR
Intervention: Glyceryl trinitrate ointment
Number of subjects: 160
Study 34803148 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocopherol acetate ointment
Number of subjects: 160
Study 32179428 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 90
Study 32179428 — intervention group
Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 90
Study 35754107 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg)
Number of subjects: 15
Study 35754107 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 15
Study 32885566 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (COCs)
Number of subjects: 425
Study 32950726 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) on dorsum of tongue
Number of subjects: 45
Study 32950726 — intervention group
Group type: COMPARATOR
Intervention: Tongue scrappers (TS)
Number of subjects: 45
Study 32950726 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue scrappers (TS) and adjunctive PDT
Number of subjects: 45
Study 36203161 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care symptoms (IPOS)
Number of subjects: 37
Study 34342185 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted alcohol consumption (based on ALDH2 rs671 polymorphism)
Number of subjects: 8922
Study 34342185 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational analysis of alcohol consumption
Number of subjects: 8922
Study 34342185 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 8922
Study 32545534 — intervention group
Group type: EXPERIMENTAL
Intervention: SR-MRehab: Un colegio emocionante (virtual reality intervention)
Number of subjects: 0
Study 32545534 — intervention group
Group type: COMPARATOR
Intervention: Standard self-regulation program (control)
Number of subjects: 0
Study 35969196 — intervention group
Group type: COMPARATOR
Intervention: Frictionless group using T-loop springs
Number of subjects: 30
Study 34922510 — intervention group
Group type: EXPERIMENTAL
Intervention: Little Holy One intervention
Number of subjects: 0
Study 34922510 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 lessons taught by Indigenous community health workers)
Number of subjects: 0
Study 35130512 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity training group (LITG, n = 20)
Number of subjects: 44
Study 35130512 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training group (HITG, n = 24)
Number of subjects: 44
Study 35130512 — intervention group
Group type: COMPARATOR
Intervention: Standardized training period (after intervention)
Number of subjects: 44
Study 35130512 — intervention group
Group type: COMPARATOR
Intervention: Self-chosen training period (after standardized training)
Number of subjects: 44
Study 33650298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent exercise (IE)
Number of subjects: 8
Study 33650298 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exercise (CE)
Number of subjects: 8
Study 33650298 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE)
Number of subjects: 8
Study 33650298 — intervention group
Group type: COMPARATOR
Intervention: Control (nonexercise)
Number of subjects: 8
Study 32167679 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril–valsartan treatment
Number of subjects: 799
Study 32167679 — intervention group
Group type: EXPERIMENTAL
Intervention: Eligible group for sacubitril–valsartan
Number of subjects: 799
Study 32755218 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial meniscal extrusion (MME) threshold of 2.5 mm
Number of subjects: 235
Study 32755218 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial meniscal extrusion (MME) threshold of 2.7 mm
Number of subjects: 235
Study 32755218 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial meniscal extrusion (MME) threshold of 2.8 mm
Number of subjects: 235
Study 32050916 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturising oil
Number of subjects: 15
Study 32050916 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 15
Study 35113424 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal delivery (NG)
Number of subjects: 105
Study 35113424 — intervention group
Group type: COMPARATOR
Intervention: Cesarean group (CG)
Number of subjects: 105
Study 35113424 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (NG and CG)
Number of subjects: 105
Study 34405547 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilaciclib
Number of subjects: 3
Study 35504519 — intervention group
Group type: EXPERIMENTAL
Intervention: Periosteal Pocket Flap Technique (PPF)
Number of subjects: 9
Study 35504519 — intervention group
Group type: COMPARATOR
Intervention: Guided Bone Regeneration (GBR)
Number of subjects: 9
Study 32858622 — intervention group
Group type: EXPERIMENTAL
Intervention: Young group (15-39 years old)
Number of subjects: 140
Study 32858622 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior group (65-90 years old)
Number of subjects: 140
Study 32858622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean day and night values
Number of subjects: 140
Study 32858622 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 140
Study 34599476 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention (1 month of theoretical and practical counselling once a year for 3 years)
Number of subjects: 300
Study 34599476 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 300
Study 34157479 — intervention group
Group type: EXPERIMENTAL
Intervention: Seat comfort (Type A)
Number of subjects: 54
Study 34157479 — intervention group
Group type: COMPARATOR
Intervention: Seat comfort (Type B)
Number of subjects: 54
Study 34118638 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0
Study 34118638 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 34118638 — intervention group
Group type: COMPARATOR
Intervention: N/A (not applicable)
Number of subjects: 0
Study 35333880 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg moxidectin
Number of subjects: 98
Study 35333880 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg moxidectin
Number of subjects: 98
Study 35333880 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg moxidectin
Number of subjects: 98
Study 35333880 — intervention group
Group type: COMPARATOR
Intervention: ivermectin
Number of subjects: 98
Study 33833172 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Fat Grafting (AFG)
Number of subjects: 57
Study 33833172 — intervention group
Group type: COMPARATOR
Intervention: No Autologous Fat Grafting (Control)
Number of subjects: 57
Study 33833172 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 57
Study 35295203 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM oral therapy combined with medicinal bath
Number of subjects: 712
Study 35295203 — intervention group
Group type: COMPARATOR
Intervention: TCM oral therapy
Number of subjects: 712
Study 36079817 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium nitrate (10 mmol, 625 mg of nitrate)
Number of subjects: 18
Study 36079817 — intervention group
Group type: COMPARATOR
Intervention: Placebo (iso-molar potassium chloride)
Number of subjects: 18
Study 33254235 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg bid (group A)
Number of subjects: 130
Study 33254235 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib 100 mg bid, then 150 mg qd (group B)
Number of subjects: 130
Study 33254235 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib (groups A and B)
Number of subjects: 130
Study 33254235 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostamatinib (group A)
Number of subjects: 130
Study 33254235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group E)
Number of subjects: 130
Study 32663055 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness induction
Number of subjects: 287
Study 32663055 — intervention group
Group type: COMPARATOR
Intervention: Mind-wandering induction
Number of subjects: 287
Study 32663055 — intervention group
Group type: COMPARATOR
Intervention: Join-the-dots task
Number of subjects: 287
Study 35932889 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate telephone smoking cessation support (TSI) for 6 weeks with pharmacotherapy
Number of subjects: 315
Study 35932889 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) - very brief advice to quit and signposting to smoking cessation services
Number of subjects: 315
Study 32209122 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox
Number of subjects: 20
Study 32209122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36095157 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training + neuromuscular electrical stimulation
Number of subjects: 48
Study 36095157 — intervention group
Group type: COMPARATOR
Intervention: Exercise training alone
Number of subjects: 48
Study 34425814 — intervention group
Group type: EXPERIMENTAL
Intervention: POC Xpert® HIV‐1 Qual test (Cepheid, Sunnyvale, CA, USA) for early infant diagnosis (EID)
Number of subjects: 45
Study 34798531 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial Scratching (ES) using pipelle's canula on D8 or D9 of menstrual cycle, followed by three cycles of ovulation induction with Clomiphene citrate and gonadotrophins and IUI
Number of subjects: 168
Study 34798531 — intervention group
Group type: COMPARATOR
Intervention: Control group (no endometrial scratching)
Number of subjects: 168
Study 34798531 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial Scratching (ES)
Number of subjects: 168
Study 34172267 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreamed intramedullary nail (UIMN)
Number of subjects: 80
Study 34172267 — intervention group
Group type: COMPARATOR
Intervention: Bridge-plating (BP)
Number of subjects: 80
Study 36243929 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50000 IU cholecalciferol weekly for three months)
Number of subjects: 40
Study 36243929 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study 33778854 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention (BI), n = 109
Number of subjects: 214
Study 33778854 — intervention group
Group type: COMPARATOR
Intervention: Sales ban only, n = 105
Number of subjects: 214